Log in

Sign up

Roger Nitsch

Advisory Board at Pureos Bioventures

CEO and President of Neurimmune; key opinion leader in neurodegenerative diseases; developer of aducanumab (Alzheimer’s disease) now in partnership with Biogen. Part-time professor at the Institute for Regenerative Medicine, University of Zurich.

Links

Teams

+8

Board of Directors

11 members

Timeline

  • Advisory Board

    Current role

Related people

BUSINESS

EVERY ORG CHART

Access the worlds's biggest network of public org charts

Learn more
A panel showing how The Org can help with contacting the right person.